quantitative
Analysis v1
Strong Support
If you're overweight or obese but don't have diabetes, taking GLP-1 drugs like Ozempic can lower your chances of having heart problems by about 1 in 4 compared to not taking them.
65
0
Evidence from Studies
Supporting (1)
65
Community contributions welcome
65
Comparison of glucagon-like peptide-1 receptor agonists vs. placebo on any cardiovascular events in overweight or obese non-diabetic patients: a systematic review and meta-analysis
Systematic Review With Meta-Analysis
Human
2024The study looked at the same weight-loss drugs and people described in the claim and found they really do lower heart problem risks by about 25%.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.